» Articles » PMID: 18205253

Occult Sporadic Insulinoma: Localization and Surgical Strategy

Overview
Specialty Gastroenterology
Date 2008 Jan 22
PMID 18205253
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Insulinomas continue to pose a diagnostic challenge to physicians, surgeons and radiologists alike. Most are intrapancreatic, benign and solitary. Biochemical diagnosis is obtained and imaging techniques to localize lesions continue to evolve. Surgical resection is the treatment of choice. Despite all efforts, an occult insulinoma (occult insulinoma refers to a biochemically proven tumor with indeterminate anatomical site before operation) may still be encountered. New localization preoperative techniques decreases occult cases and the knowledge of the site of the mass before surgery allows to determine whether enucleation of the tumor or pancreatic resection is likely to be required and whether the tumor is amenable to removal via a laparoscopic approach. In absence of preoperative localization and intraoperative detection of an insulinoma, blind pancreatic resection is not recommended.

Citing Articles

A Long Way to Find a Small Tumor: The Hunt for an Insulinoma.

Arjunan D, Grossman A, Singh H, Rai R, Bal A, Dutta P JCEM Case Rep. 2024; 2(11):luae192.

PMID: 39465233 PMC: 11505447. DOI: 10.1210/jcemcr/luae192.


Mechanism and recent updates on insulin-related disorders.

Kumar S, Senapati S, Bhattacharya N, Bhattacharya A, Maurya S, Husain H World J Clin Cases. 2023; 11(25):5840-5856.

PMID: 37727490 PMC: 10506040. DOI: 10.12998/wjcc.v11.i25.5840.


Insulinoma with peripheral neuropathy: a case report.

Vinhosa Bastos Jr M, da Silva Caires I, Boschi Portella R, Nascimento Martins R, Reverdito R, Reverdito S J Med Case Rep. 2023; 17(1):241.

PMID: 37308982 PMC: 10262407. DOI: 10.1186/s13256-023-03963-5.


The incidence of insulinoma in Western Sweden between 2002 and 2019.

Svensson E, Muth A, Hedenstrom P, Ragnarsson O Ann Gastroenterol. 2022; 35(4):434-440.

PMID: 35784630 PMC: 9210785. DOI: 10.20524/aog.2022.0707.


Insulinoma-Accurate Preoperative Localization Is the Key to Management: An Initial Experience.

Sharma A, Varshney P, Kasliwal R, Nagar A, Venkatatelikicherla K, Sarin S Indian J Surg Oncol. 2022; 13(2):403-411.

PMID: 35782810 PMC: 9240150. DOI: 10.1007/s13193-022-01534-6.


References
1.
Gutelius B, Korytkowski M, Carty S, Hamad G . Diagnosis and minimally invasive resection of an insulinoma: report of an unusual case and review of the literature. Am Surg. 2007; 73(5):520-4. View

2.
Goletti O, Celona G, Monzani F, Caraccio N, Zocco G, Lippolis P . Laparoscopic treatment of pancreatic insulinoma. Surg Endosc. 2003; 17(9):1499. DOI: 10.1007/s00464-002-4273-7. View

3.
Bernard B, Capello A, van Hagen M, Breeman W, Srinivasan A, Schmidt M . Radiolabeled RGD-DTPA-Tyr3-octreotate for receptor-targeted radionuclide therapy. Cancer Biother Radiopharm. 2004; 19(2):173-80. DOI: 10.1089/108497804323071940. View

4.
McAuley G, Delaney H, Colville J, Lyburn I, Worsley D, Govender P . Multimodality preoperative imaging of pancreatic insulinomas. Clin Radiol. 2005; 60(10):1039-50. DOI: 10.1016/j.crad.2005.06.005. View

5.
Norton J . Intraoperative methods to stage and localize pancreatic and duodenal tumors. Ann Oncol. 1999; 10 Suppl 4:182-4. View